课题基金 / 基金详情

CENTRAL IMMUNOLOGY LAB FOR AIDS VACCINE CLINICAL TRIALS

CENTRAL IMMUNOLOGY LAB FOR AIDS VACCINE CLINICAL TRIALS
艾滋病疫苗临床试验中央免疫学实验室
批准号:
6158929
负责人:
Dani P. Bolognesi
金额:
$25.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1996
资助国家:
美国
项目状态:
已结题
起止时间:
1996-04-17 至 2003-04-16

项目摘要

项目成果

Dani P. Bolognesi的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This Contract provides for the adaptation, development, quality assurance, and performance of routine and innovative humoral and cellular immunologic, as well as virologic evaluations, on specimens from volunteers in NIAID-sponsored multicenter AIDS Vaccine Clinical Trials. Limited comparative assays with specimens from non-human primates in AIDS vaccine preclinical trials, HIV-infected individuals, or volunteers in non-NIAID-sponsored trials of candidate AIDS vaccines are also performed by the Contractor. The immunological and virological assay data is electronically transmitted to the AIDS Vaccine Evaluation Group (AVEG) Statistical and Coordinating Center for further analysis. The Principal Investigator and Co-Investigator(s) collaborate in the design and development of AVEG Clinical Trial Protocols, providing scientific leadership regarding the evaluation of vaccine immunogenicity.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
CD8+ T cell mediated noncytolytic inhibition of human immunodeficiency virus type I.
CD8 T 细胞介导的 I 型人类免疫缺陷病毒的非溶细胞性抑制。
DOI: 10.2741/tomaras
发表时间: 2001
期刊: Frontiers in bioscience : a journal and virtual library
影响因子: --
作者: [Tomaras,GD, Greenberg,ML]
通讯作者: Greenberg,ML
CD8+ T cell-mediated suppressive activity inhibits HIV-1 after virus entry with kinetics indicating effects on virus gene expression.
CD8 T 细胞介导的抑制活性在病毒进入后抑制 HIV-1,其动力学表明对病毒基因表达的影响。
DOI: 10.1073/pnas.97.7.3503
发表时间: 2000
期刊: Proceedings of the National Academy of Sciences of the United States of America
影响因子: 11.1
作者: [Tomaras,GD, Lacey,SF, McDanal,CB, Ferrari,G, Weinhold,KJ, Greenberg,ML]
通讯作者: Greenberg,ML
CD8 CTL responses in vaccines: emerging patterns of HLA restriction and epitope recognition.
疫苗中的 CD8 CTL 反应:HLA 限制和表位识别的新模式。
DOI: 10.1016/s0165-2478(01)00264-4
发表时间: 2001
期刊: Immunology letters
影响因子: 4.4
作者: [Ferrari,G, Neal,W, Jones,A, Olender,N, Ottinger,J, Ha,R, McElrath,MJ, Goepfert,P, Weinhold,KJ]
通讯作者: Weinhold,KJ
CORE--DEVELOPMENTAL CORE
  • 批准号:
    6217094
  • 项目类别:
  • 资助金额:
    $8.53万
  • 财政年份:
    1999
  • 负责人:
    Dani P. Bolognesi
  • 依托单位:
CORE--DEVELOPMENTAL CORE
  • 批准号:
    6099439
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    1998
  • 负责人:
    Dani P. Bolognesi
  • 依托单位:
CORE--DEVELOPMENTAL CORE
  • 批准号:
    6234943
  • 项目类别:
  • 资助金额:
    $15.14万
  • 财政年份:
    1997
  • 负责人:
    Dani P. Bolognesi
  • 依托单位:
CENTRAL IMMUNOLOGY LAB FOR AIDS VACCINE CLINICAL TRIALS
  • 批准号:
    6158928
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    1996
  • 负责人:
    Dani P. Bolognesi
  • 依托单位:
海外基金